Mr. Pilnik served in several leadership positions during his 25-year career at Eli Lilly and Company.  Mr. Pilnik retired from Eli Lilly as Group Vice President and Chief Marketing Officer, where he was directly responsible for commercial strategy, market research, new product planning and the medical marketing interaction. Prior to that, Mr. Pilnik served as President of Eli Lilly Europe, Middle East and Africa and the Commonwealth of the independent States (CIS), a regional organization of former Soviet Republics, where he oversaw 50 countries and positioned Eli Lilly as the fastest growing pharmaceutical company in the region. Mr. Pilnik also held several marketing and sales management positions in the United States, Europe and Latin America during his tenure at Eli Lilly. Mr. Pilnik serves as EVP and President of Quintiles Commercial Solutions, a global pioneer in pharmaceutical services. Mr. Pilnik  sits on the board of directors of Elan Corporation, a successful bio-pharmaceutical company with research, development and commercial activities directed towards neurodegenerative disease, including Alzheimer’s and Parkinson’s disease. Mr. Pilnik holds a B.A. in economics from Duke University and an MBA from the Kellogg School of Management at Northwestern University.